1/140
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
what is the most common neurobehavioral disorder amongst children and adolescent
ADHD
why are boys more likely than girls to be diagnosed with ADHD
boys often present with symptoms of hyperactivity while girls present more with inattentiveness and are more likely to go undiagnosed
most noticeable symptom of ADHD for: preschoolers
hyperactivity
most noticeable symptom of ADHD for: school age
inattentiveness
most noticeable symptom of ADHD for: adolescents/college/adults
less hyperactivity —> more restlessness
what is the most common reason for developing ADHD
genetics (75% heritable)
what are uncommon risk factors for developing ADHD
low birth weight/premature
prenatal exposure: nicotine, alcohol, acetaminophen
traumatic brain injury
lead and toxin exposure at young age
Patients with ADHD showed delayed development of what by 2-3 years
Prefrontal cortex
function of prefrontal cortex
attention
problem solving
impulse control
emotional regulation
ADHD is affected by which neurotransmitters
deficiency in dopamine + norepinephrine
functions of norepinephrine and dopamine in ADHD
maintain attention
regulate mood
resist distractions
effects of too much or too little norepinephrine and dopamine
too much = fatigued
too little= stressed
distracted
disorganized
forgetful
impulsive
effects of maintaining a good balance of norepinephrine and dopamine
focused
organized
responsible
Diagnostic criteria of ADHD: persistent pattern of inattention and or hyperactivity impulsivity
Present for 6+ months
Present in 2+ settings (home & school)
Present before age 12
patients younger than 18 must present with how many symptoms of ADHD
6
patients older than 18 must present with how many symptoms of ADHD
5
9 inattentive symptoms of ADHD
fails to give close attention to details/makes careless mistakes
difficulty sustaining attention
does not seem to listen
does not follow instructions
difficulty organizing
avoids or dislikes tasks that requires sustained efforts
often loses things
easily distracted
forgetful
9 hyperactive/impulsive symptoms of ADHD
fidgets/squirms in seat
leaves seat when remaining seated is expected
turns about and climbs (adults = restlessness)
unable to play or engage in activities quietly
“on the go” or “driven by a motor”
talks excessively
blurts out answers
difficulty waiting turn
interrupts or intrudes on others
standard of care for young patients with ADHD
behavior management therapy
parent training in behavior management
behavioral classroom intervention
Stimulant drugs used for ADHD
controlled II
methylphenidate
amphetamines
Non-Stimulants used for treatment of ADHD
Norepinephrine Reuptake Inhibitors
Atomoxetine
Viloxazine
Alpha-2 Agonists
Clonidine
Guanfacine
Off label non-stimulants used to treat ADHD
Bupropion
Modafanil
TCAs (imipramine or nortriptyline)
What class of medications is most effective for the treatment of ADHD
stimulants
Are methylphenidates or amphetamines more effective
equally effective- fail one agent, switch to the other class
Preschoolers (4-5 years old) treatment options for ADHD
First line: behavior therapy
Second line: stimulant (methylphenidate preferred)
which population is methylphenidate preferred for the treatment of ADHD
preschoolers- age 4-5
Elementary (6-11) + Adolescent (12-18) treatment options for ADHD
Behavior therapy + Stimulant
behavior therapy alone not recommended- may not be as effective in older patients
either amphetamines or methylphenidates can be used
Dose limiting side effects of stimulants
decreased appetite
insomnia
how to reduce appetite loss seen when taking stimulants for ADHD
large meal in morning before effect of drug kicks in
large meal for dinner once drug wears off
how to reduce insomnia seen when taking stimulants for ADHD
do not give dose too late or use a shorter acting agent
how to reduce anxiety seen when taking stimulants for ADHD
reduce dose or use extended release
how to reduce stomach upset seen when taking stimulants for ADHD
take with food
how to reduce irritability seen when taking stimulants for ADHD
extended release formulation
true or false: every patient receiving a stimulant should receive a baseline ECG before initiating therapy
false- not routinely recommended
which patient population should receive a baseline ECG before initiating stimulants
family history of cardiac abnormalities or sudden death
abnormal cardiac findings on physical exams (heart murmur)
what is the preferred stimulant for patients less than 4-5
methylphenidate
Methylphenidate immediate release duration of action
3-6 hours
Methylphenidate immediate release dosing
2-3x/day
advantages to taking immediate release methylphenidate
easier to titrate for kids
lower risk of insomnia
may add as an afternoon dose to long acting stimulants
how should immediate release methylphenidate be taken
empty stomach
disadvantages to immediate release methylphenidate
short duration
rebound irritability
Methylphenidate extended release duration
Metadate ER or Ritalin SR tablet= 3-8 hours
bead filled capsule= 6-9 hours
Aptensio XR= 12 hours
which extended release form of methylphenidate needs to be swallowed whole
metadate sr or ritalin er tablets
which extended release form of methylphenidate needs to be taken on an empty stomach for optimal absorption
metadate sr or ritalin er tablets
which extended release form of methylphenidate can be opened and sprinkled onto applesauce
Metadate CD/Ritalin LA bead filled capsules (do not chew bead)
Aptensio XR
Jornay
Azstarys
benefits to using extended release methylphenidate
does not require midday dosing when the child is in school
some can be opened and sprinkled on applesauce or yogurt
disadvantages to using extended release methylphenidate
insomnia if medication is dosed later in the day
some may not last the entire day
what is the most commonly prescribed methylphenidate
OROS methylphenidate
mechanism of action for OROS methylphenidate
triphasic release= stimulate three times a day dosing
OROS methylphenidate stands for
osmotic controlled release oral system
duration of action OROS methylphenidate
10-12 hours
counseling point for OROS methylphenidate
pellet will come out in stool but it’s just the casing and does not contain any medication
do not crush, chew, or manipulate in anyway
advantages to OROS methylphenidate
true once daily dosing
lower abuse potential
disadvantages to OROS methylphenidate
expensive + medication shortages
which stimulants are available as a transdermal patch
methylphenidate
dextroamphetamine
which patient population is the methylphenidate transdermal patch indicated for
Children (6-17 years old)
how long does it take for methylphenidate patch to start working
2 hours (place patch on child before they wake up)
How long does the effect of methylphenidate transdermal patch last after removing the patch
additional 3 hours
what is the overall total duration for the methylphenidate transdermal patch
10-12 hours
advantages to using the methylphenidate transdermal patch
customize the duration by varying the wear time
minimal GI upset
disadvantages to using the methylphenidate transdermal patch
low compliance- especially in children
insomnia if patch is not removed early enough
erythema (redness) and irritation
Alternative Extended Release Methylphenidate Formulations: duration of action
Oral suspension
Chewable Tablet
ODT (orally disintegrating tablet)
Oral suspension: 8-12 hours
Chewable Tablet: 8-12 hours
ODT (orally disintegrating tablet): up to 12 hours
brand name of a specially designed extended release capsule for methylphenidate
Jornay PM
Jornay PM is useful for which patient population
struggles with early morning symptoms of ADHD
Jornay PM Dosing
Administer the night before in evening (6:30-9:30 pm)
Jornay PM MOA
taken in the evening the night before
outer capsule takes 10 hours to dissolve to prevent release of medication
inner capsule provides extended release of the medication thoughout the day
Jornay PM administration
contains bead filled capsule that can be opened and sprinkled on applesauce
duration of action for dexmethylphenidate immediate release
3-6 hours
duration of action for dexmethylphenidate extended release
8-12 hours
Azstarys generic form
serdexmethylphenidate + dexmethylphenidate
Azstarys duration of action
10-13 hours
Azstarys MOA
serdexmethylphenidate= prodrug
dexmethylphenidate= more active isomer
(able to give a longer duration of action)
amphetamines mechanism of action
blocks reuptake of norepinephrine and dopamine
enhances release of norepinephrine and dopamine
how does methylphenidate differ from amphetamines in their mechanism of action
amphetamines are also able to enhance the release of dopamine and norepinephrine
methylphenidate can only inhibit the reuptake
is methylphenidate or amphetamines more potent
amphetamines
dextroamphetamine duration of action:
immediate release tablet
sustained release bead capsule
immediate release liquid
immediate release tablet: 4-6 hours (bid-tid)
sustained release bead capsule: 6-10 hours (daily-bid)
immediate release liquid: 4-6 hours (bid-tid)
how should dextroamphetamine transdermal patch be applied
2 hours before effect is needed
when should dextroamphetamine transdermal patch be removed
within 9 hours of use
what is the most commonly prescribed form of amphetamine
mixed amphetamine salts (adderall)
mixed amphetamine salts duration of action (immediate release vs extended release)
Adderall immediate release: 4-8 hours (daily-tid)
Adderall XR: 8-12 hours (once daily)
Evekeo: 4-6 hours
Mydayis TM: 16 hours
which amphetamine salt is a mix of dextro and levoamphetamine
adderall immediate release
dextroamphetamine has more activity of which neurotransmitter
more dopamine than norepinephrine activity
which mixed amphetamine salt is available in ODT form
evekeo
which amphetamine salt it long acting, triple bead
mydaisTM
which amphetamine salt is immediate release, single salt, 1:1 ration of dextro + levoamphetamine
Evekeo
which is the longest acting mixed amphetamine salt
MydayisTM
Extended release amphetamine drugs: oral suspension
Dyanavel XR
Extended release amphetamine drugs: oral disintegrating tablet
Adzenys
Dyanavel XR duration of action
8-13 hours (extended release oral suspension)
Adzenys duration of action
9-12 hours (extended release oral disintegrating tablet)
prodrug of dexamphetamine
lisdexamphetamine
Lisdexamphetamine MOA
pro-drug requires activation via hydrolysis
lisdexamphetamine duration of action
10-12 hours (may be delayed 2-3 hours)
why may there be a delay of duration for lisdexamphetamine
requires hydrolysis to become active (may be delayed 2-3 hours)
which stimulant used in the treatment of ADHD is also approved for moderate-severe binge eating disorder in adults
lisdexamphetamine
why does lisdexamphetamine have a lower potential for abuse
slow onset of action
advantages for using lisdexamphetamine
once daily dose
less abuse
can sprinkle capsule in water/yogurt/juice
chewable formulation available
disadvantages to lisdexamphetamine
expensive
delayed onset of action
why are all stimulants controlled and what level are they
schedule II
euphoric effects
performance enhancing effects
which stimulants have less misuse potential
OROS methylphenidate
methylphenidate
lisdexamphetamine